Clinical trial · Interventional
Image Guided Brachytherapy in Locally Advanced Cancer Cervix
Implementation of Image Guided Brachytherapy in Treatment of Patients With Locally Advanced Cancer Cervix
NCT04767425CI-TRIAL-00050251unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is non comparative prospective interventional study with some areas for observational research to implement based image guided adaptive cervical cancer brachytherapy ( BT ) combined with Intensity Modulated Radiotherapy ( IMRT ) / Volumetric Modulated Arc Therapy ( VMAT) external beam radiotherapy (EBRT) ± chemotherapy (ChT) , and to take advantage of its full potential.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Cervix | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Brachytherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Experimental
- interventionNames
- Radiation: Brachytherapy
Primary outcomes (1)
- measure
- Reduction of tumor size
- timeFrame
- "up to 3 months "
- description
- Complete response , defined as the disappearance of all evidence of disease by physical examination and MRI pelvis
Secondary outcomes (2)
- measure
- survival rates
- timeFrame
- " 2 years "
- description
- survival rates including disease free survival, overall survival
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * • Pathological confirmation squamous carcinoma, adenocarcinoma or adeno-squamous carcinoma of the uterine cervix. * Locally advanced cervical cancer , Federation of Gynecology and Obstetrics staging system FIGO stage IB ,FIGO stage IIA , FIGO stage IIB , FIGO stage IIIA, FIGO stage and FIGO stage IVA (and nodal status according to TNM) in whom definitive radio-chemotherapy with curative intent is planned are qualified for the study . * No evidence of distant metastasis or other malignancy. * No other comorbid disease that would affect patient survival Exclusion Criteria: * • FIGO stage IA , FIGO stage and Distant metastatic disease or presence of other malignancy . * Presence of other comorbid disease that would affect patient survival
References
Publications (0)
Data not yet available
No reference posted for this study.